ABVC BioPharma ABVC
ABVC BioPharma, Inc. entered into a securities purchase agreement with Lind Global Fund II
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001213900-23-088524
- Document
- 8-K
- Exhibit 10.1
- Securities purchase agreement
- Exhibit 10.2
- Form of note
- Exhibit 10.3
- Form of warrant
- Exhibit 10.4
- First amendment to security agreement
- Exhibit 10.5
- First amendment to guarantor security agreement
- Exhibit 10.6
- First amendment to guaranty
- Signs a material agreement (1.01)
- Sells unregistered shares (3.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Karyopharm Therapeutics KPTI public float $37M, Jun 30, 2025
- BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
- Annovis Bio ANVS public float $36M, Jun 30, 2025
- Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025
- Grace Therapeutics GRCE public float $35M, Sep 30, 2025